Healthcare

Shares of telehealth provider Hims & Hers Health faced significant pressure this week following a regulatory confrontation with the U.S....

Lyell Immunopharma has initiated its crucial Phase 3 clinical trial, named PiNACLE - H2H, for its next-generation CAR T-cell therapy...

Ensign's stock demonstrated continued strength in the wake of its latest quarterly earnings release, which substantially outpaced market expectations. The...

Healthcare real estate investment trust Ventas is making a powerful statement to its shareholders through decisive financial actions. In the...

A dramatic 190% explosion in one business segment and an 870 basis point margin expansion would capture any investor's attention....

Despite posting disappointing quarterly results and facing continued share price pressure, market analysts are demonstrating notable optimism toward CareDx. The...

The U.S. Food and Drug Administration (FDA) has launched a significant regulatory action, placing telehealth company Hims & Hers under...

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market...

As Alight shares touch new annual lows, an unexpected strategic partnership with digital health firm Sword Health has emerged as...